Markets › Stocks › SAMRATPH
SA

Samrat Pharmachem Ltd-$

NSE: SAMRATPHBSE: 530125Healthcare
₹209.10
▲ +0.84%
NSE · 15-min delayed
Mkt Cap
₹77 Cr
P / E
10.8
P / B
1.1
ROE
-4.8%
52W High
₹389.00
52W Low
₹190.00
Key Metrics
Market Cap
₹77 Cr
P / E
10.8
P / B
1.1
ROCE
-2.6%
ROE
-4.8%
Div Yield
-
Revenue · ₹ Cr
137
FY20
179
FY21
222
FY22
311
FY23
282
FY24
286
FY25
290
FY26
Net Profit · ₹ Cr
4
FY20
5
FY21
17
FY22
17
FY23
2
FY24
7
FY25
-3
FY26
EPS · ₹ per share
₹5.0
FY19
₹13.7
FY20
₹17.3
FY21
₹55.6
FY22
₹53.8
FY23
₹7.0
FY24
₹23.0
FY25
Q1 2026 snapshot
Sales
₹71 Cr
Operating profit
-
OPM
-
Net profit
₹-2 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
42/100
Valuation
Strong
10.8×
Growth
Avg
+7.2%
Profitability
Bad
-3.7%
Performance
Bad
-39.9%
Entry Point
Strong
54%
Red Flags
Strong
0 flags
Shareholding Pattern
49.1%Promoter
Promoter49.1%
FII3.2%
Public47.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue63.6771.176.3478.9263.8371.47
Net Profit2.785-0.399-0.229-0.587-0.46-2.036
NPM %4.4%-0.6%-0.3%-0.7%-0.7%-2.8%
AlertPre-trade